Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis
Crossref DOI link: https://doi.org/10.1007/s40744-019-00177-4
Published Online: 2019-11-09
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Reed, George W.
Gerber, Robert A.
Shan, Ying
Takiya, Liza
Dandreo, Kimberly J.
Gruben, David
Kremer, Joel
Wallenstein, Gene
Funding for this research was provided by:
Pfizer Inc.
Text and Data Mining valid from 2019-11-09
Version of Record valid from 2019-11-09
Article History
Received: 22 August 2019
First Online: 9 November 2019